Nomura Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.69M | Sell |
30,000
-3,862
| -11% | -$225K | ﹤0.01% | 978 |
|
|
2025
Q4 | $2.01M | Buy |
+33,862
| New | +$1.84M | ﹤0.01% | 1092 |
|
|
2025
Q3 | – | Sell |
-34,435
| Closed | -$1.97M | – | 1870 |
|
|
2025
Q2 | $1.89M | Sell |
34,435
-57,955
| -63% | -$3.41M | ﹤0.01% | 854 |
|
|
2025
Q1 | $6.53M | Sell |
92,390
-34,452
| -27% | -$2.32M | 0.01% | 611 |
|
|
2024
Q4 | $8.34M | Buy |
+126,842
| New | +$8.5M | 0.01% | 573 |
|
|
2024
Q2 | – | Sell |
-1,491,255
| Closed | -$124M | – | 1769 |
|
|
2024
Q1 | $130M | Sell |
1,491,255
-641,682
| -30% | -$57.4M | 0.33% | 43 |
|
|
2023
Q4 | $206M | Sell |
2,132,937
-707,873
| -25% | -$62.6M | 0.56% | 22 |
|
|
2023
Q3 | $251M | Buy |
+2,840,810
| New | +$253M | 0.71% | 25 |
|
|
2022
Q4 | – | Sell |
-200,653
| Closed | -$17M | – | 1510 |
|
|
2022
Q3 | $17M | Buy |
200,653
+192,653
| +2,408% | +$17.2M | 0.07% | 218 |
|
|
2022
Q2 | $680K | Buy |
+8,000
| New | +$637K | ﹤0.01% | 1055 |
|
|
2021
Q4 | – | Sell |
-5,985
| Closed | -$463K | – | 2242 |
|
|
2021
Q3 | $463K | Sell |
5,985
-1,935
| -24% | -$153K | ﹤0.01% | 1449 |
|
|
2021
Q2 | $661K | Sell |
7,920
-21,738
| -73% | -$1.72M | ﹤0.01% | 1221 |
|
|
2021
Q1 | $2.24M | Sell |
29,658
-15,895
| -35% | -$1.3M | 0.01% | 814 |
|
|
2020
Q4 | $3.99M | Sell |
45,553
-19,536
| -30% | -$1.55M | 0.01% | 632 |
|
|
2020
Q3 | $4.96M | Sell |
65,089
-147,784
| -69% | -$15M | 0.01% | 463 |
|
|
2020
Q2 | $26.2M | Buy |
212,873
+168,884
| +384% | +$16.8M | 0.09% | 153 |
|
|
2020
Q1 | $3.71M | Sell |
43,989
-17,811
| -29% | -$1.53M | 0.02% | 364 |
|
|
2019
Q4 | $5.22M | Sell |
61,800
-27,799
| -31% | -$2.1M | 0.02% | 438 |
|
|
2019
Q3 | $5.8M | Sell |
89,599
-85,077
| -49% | -$6.55M | 0.02% | 428 |
|
|
2019
Q2 | $14.7M | Buy |
174,676
+17,358
| +11% | +$1.48M | 0.07% | 244 |
|
|
2019
Q1 | $14.1M | Buy |
157,318
+49,763
| +46% | +$4.61M | 0.06% | 243 |
|
|
2018
Q4 | $9.16M | Sell |
107,555
-6,568
| -6% | -$625K | 0.03% | 346 |
|
|
2018
Q3 | $11.3M | Sell |
114,123
-51,044
| -31% | -$5.1M | 0.04% | 338 |
|
|
2018
Q2 | $15.6M | Buy |
165,167
+153,776
| +1,350% | +$13.5M | 0.05% | 285 |
|
|
2018
Q1 | $922 | Buy |
+11,391
| New | +$978K | ﹤0.01% | 1071 |
|
|
2017
Q4 | – | Sell |
-19,762
| Closed | -$1.84M | – | 1521 |
|
|
2017
Q3 | $1.84M | Buy |
19,762
+18,340
| +1,290% | +$1.62M | ﹤0.01% | 877 |
|
|
2017
Q2 | $129K | Sell |
1,422
-1,280
| -47% | -$116K | ﹤0.01% | 1415 |
|
|
2017
Q1 | $237K | Buy |
+2,702
| New | +$240K | ﹤0.01% | 1134 |
|
|
2016
Q4 | – | Sell |
-962
| Closed | -$90K | – | 1542 |
|
|
2016
Q3 | $90K | Sell |
962
-1,338
| -58% | -$126K | ﹤0.01% | 1101 |
|
|
2016
Q2 | $179K | Sell |
2,300
-16,594
| -88% | -$1.41M | ﹤0.01% | 1054 |
|
|
2016
Q1 | $1.56M | Buy |
18,894
+18,766
| +14,661% | +$1.53M | 0.01% | 610 |
|
|
2015
Q4 | $13K | Buy |
128
+77
| +151% | +$8.04K | ﹤0.01% | 1808 |
|
|
2015
Q3 | $5K | Sell |
51
-32,732
| -100% | -$4.37M | ﹤0.01% | 1609 |
|
|
2015
Q2 | $4.27M | Buy |
32,783
+32,172
| +5,265% | +$3.99M | 0.01% | 503 |
|
|
2015
Q1 | $73K | Sell |
611
-368
| -38% | -$39K | ﹤0.01% | 1627 |
|
|
2014
Q4 | $86K | Sell |
979
-20,295
| -95% | -$1.69M | ﹤0.01% | 2162 |
|
|
2014
Q3 | $1.5M | Sell |
21,274
-15,988
| -43% | -$1.05M | ﹤0.01% | 1247 |
|
|
2014
Q2 | $2.3M | Sell |
37,262
-22,290
| -37% | -$1.35M | ﹤0.01% | 1058 |
|
|
2014
Q1 | $4.07M | Buy |
59,552
+50,120
| +531% | +$3.69M | ﹤0.01% | 836 |
|
|
2013
Q4 | $661K | Sell |
9,432
-17,534
| -65% | -$1.19M | ﹤0.01% | 1158 |
|
|
2013
Q3 | $1.95M | Buy |
26,966
+20,500
| +317% | +$1.36M | 0.01% | 839 |
|
|
2013
Q2 | $361K | Buy |
+6,466
| New | +$403K | ﹤0.01% | 1509 |
|
Other funds holding BMRN
VCM
VPM
Nomura Holdings's BMRN Position: Q1 2026 in Review
Nomura Holdings reduced its BioMarin Pharmaceuticals (BMRN) stake by 11% in Q1 2026, selling an estimated $225K and leaving 30,000 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #978.
Nomura Holdings first reported a position in BMRN in Q2 2013 and has held it in 42 quarters since. The position peaked at $251M in Q3 2023. 554 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.
- Nomura Holdings held 30,000 shares of BioMarin Pharmaceuticals worth $1.69M as of Q1 2026.
- Nomura Holdings sold 3,862 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $225K.
- BioMarin Pharmaceuticals made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #978 holding.
- Nomura Holdings first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 42 quarters since.
- Nomura Holdings's BioMarin Pharmaceuticals position peaked at $251M in Q3 2023.
- 554 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.